Cost-effectiveness of new guidelines for adjuvant systemic t…
Cost-effectiveness of new guidelines for adjuvant systemic therapy for patients with primary breast cancer.
Article, Chapter
Authors:
W. Kievit
Publication:
Volume:16,
Issue:12,
Page(s):1874-1881
Published:
2005
We were unable to find direct full text links for this item.